Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday''s Mid-Day Session Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM ) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB ) gained 82.4% to $0.9819 after the company announced the commercial launch of its left-heart access products. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN ) surged 70% to $2.85 after the company reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed levels of disease-related biomarkers in people with ALS were steady, in contrast to a statistically significant decline portrayed in biomarkers when PrimeC was administered. Epizyme, Inc. (NASDAQ: EPZM ) rose 60.4% to $1.53. Ipsen SA (OTC: IPSEY ) agreed to acquire Epizyme at $1.45 per share for approximately $247 million, plus one contingent value right (CVR) per share. Axsome Therapeutics, Inc. (NASDAQ: AXSM ) shares jumped 40.4% to $34.34 after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive disorder.